RxDoctor Payments Data

Clayton Roberts, DO

Family Medicine · Stephenville, TXNPI 1174695530

Payments from drug & device makers

$636in general payments, 2019–2025

Across 33 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$284
  • GE HealthCare$72
  • Dexcom, Inc.$63
  • Astellas Pharma US Inc$48
  • Novo Nordisk$42
  • Amgen$31
  • plus $96 from 6 others

What the payments were for

  • Food & beverage$636100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$636 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$359,500
Medicare patients
465
Services billed
14,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban254$185,828
OzempicSemaglutide120$118,780
MounjaroTirzepatide82$112,046
JardianceEmpagliflozin85$88,984
AustedoDeutetrabenazine28$88,501
FarxigaDapagliflozin Propanediol65$70,288
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$55,576
JanuviaSitagliptin Phosphate47$50,587
TrulicityDulaglutide39$49,678
XareltoRivaroxaban17$23,794
MyrbetriqMirabegron50$21,444
BriviactBrivaracetam12$18,202
TradjentaLinagliptin17$16,646
Fluticasone-SalmeterolFluticasone Propion/Salmeterol92$14,939
EntrestoSacubitril/Valsartan14$14,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Tresiba$42$130,135137 claims
AstraZenecaFarxiga$13$70,28865 claims
GSKTrelegy Ellipta, Breo Ellipta$17$65,93495 claims
MerckJanuvia$20$50,58747 claims
Astellas Pharma US IncMyrbetriq$48$21,44450 claims
AbbVieLinzess$284$13,61816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Stephenville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →